IGM Biosciences, Inc. Stock-Based Compensation
IGM Biosciences, Inc. reported Stock-Based Compensation of $8.20 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-07-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2025-07-31
- IGM Biosciences, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-06-30 was $2.71M, a 67.81% decline year-over-year.
- IGM Biosciences, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-03-31 was $5.49M, a 30.74% decline year-over-year.
- IGM Biosciences, Inc. share-based payment arrangement, noncash expense for the quarter ending 2024-12-31 was $5.71M, a 38.14% decline year-over-year.
- IGM Biosciences, Inc. share-based payment arrangement, noncash expense for the quarter ending 2024-09-30 was $16.20M, a 35.54% increase year-over-year.
- IGM Biosciences, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $38.27M, a 17.79% decline from fiscal 2023.
- IGM Biosciences, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $46.55M, a 4.11% increase from fiscal 2022.
- IGM Biosciences, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $44.71M, a 72.81% increase from fiscal 2021.
- IGM Biosciences, Inc. share-based payment arrangement, noncash expense for fiscal 2021 was $25.87M, a 206.04% increase from fiscal 2020.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2025-06-30 | $2.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $8.20M 10-Q · filed 2025-07-31 | $13.91M derived: sum of 3 quarters · filed 2025-07-31 | $30.12M derived: sum of 4 quarters · filed 2025-07-31 |
| 2025-03-31 | $5.49M 10-Q · filed 2025-05-13 | $11.20M derived: sum of 2 quarters · filed 2025-05-13 | $27.40M derived: sum of 3 quarters · filed 2025-05-13 | $35.83M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-12-31 | $5.71M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $21.92M derived: sum of 2 quarters · filed 2025-03-06 | $30.34M derived: sum of 3 quarters · filed 2025-07-31 | $38.27M 10-K · filed 2025-03-06 |
| 2024-09-30 | $16.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $24.63M derived: sum of 2 quarters · filed 2025-07-31 | $32.55M 10-Q · filed 2024-11-08 | $41.79M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-06-30 | $8.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $16.35M 10-Q · filed 2025-07-31 | $25.59M derived: sum of 3 quarters · filed 2025-07-31 | $37.54M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-03-31 | $7.92M 10-Q · filed 2025-05-13 | $17.16M derived: sum of 2 quarters · filed 2025-05-13 | $29.11M derived: sum of 3 quarters · filed 2025-05-13 | $43.42M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $9.24M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $21.19M derived: sum of 2 quarters · filed 2025-03-06 | $35.50M derived: sum of 3 quarters · filed 2025-03-06 | $46.55M 10-K · filed 2025-03-06 |
| 2023-09-30 | $11.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $26.26M derived: sum of 2 quarters · filed 2024-11-08 | $37.31M 10-Q · filed 2024-11-08 | $48.42M derived: sum of 4 quarters · filed 2025-03-06 |
| 2023-06-30 | $14.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $25.36M 10-Q · filed 2024-08-14 | $36.47M derived: sum of 3 quarters · filed 2025-03-06 | $47.28M derived: sum of 4 quarters · filed 2025-03-06 |
| 2023-03-31 | $11.05M 10-Q · filed 2024-05-08 | $22.16M derived: sum of 2 quarters · filed 2025-03-06 | $32.97M derived: sum of 3 quarters · filed 2025-03-06 | $44.26M derived: sum of 4 quarters · filed 2025-03-06 |
| 2022-12-31 | $11.11M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $21.93M derived: sum of 2 quarters · filed 2025-03-06 | $33.21M derived: sum of 3 quarters · filed 2025-03-06 | $44.71M 10-K · filed 2025-03-06 |
| 2022-09-30 | $10.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $22.10M derived: sum of 2 quarters · filed 2023-11-13 | $33.60M 10-Q · filed 2023-11-13 | $42.15M derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-06-30 | $11.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $22.79M 10-Q · filed 2023-08-03 | $31.33M derived: sum of 3 quarters · filed 2024-03-07 | $37.55M derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-03-31 | $11.50M 10-Q · filed 2023-05-12 | $20.05M derived: sum of 2 quarters · filed 2024-03-07 | $26.26M derived: sum of 3 quarters · filed 2024-03-07 | $31.87M derived: sum of 4 quarters · filed 2024-03-07 |
| 2021-12-31 | $8.55M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $14.76M derived: sum of 2 quarters · filed 2024-03-07 | $20.37M derived: sum of 3 quarters · filed 2024-03-07 | $25.87M 10-K · filed 2024-03-07 |
| 2021-09-30 | $6.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $11.82M derived: sum of 2 quarters · filed 2022-11-03 | $17.32M 10-Q · filed 2022-11-03 | $19.91M derived: sum of 4 quarters · filed 2023-03-30 |
| 2021-06-30 | $5.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $11.11M 10-Q · filed 2022-08-08 | $13.70M derived: sum of 3 quarters · filed 2023-03-30 | $16.29M derived: sum of 4 quarters · filed 2023-03-30 |
| 2021-03-31 | $5.50M 10-Q · filed 2022-05-09 | $8.09M derived: sum of 2 quarters · filed 2023-03-30 | $10.68M derived: sum of 3 quarters · filed 2023-03-30 | $12.63M derived: sum of 4 quarters · filed 2023-03-30 |
| 2020-12-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $5.18M derived: sum of 2 quarters · filed 2023-03-30 | $7.13M derived: sum of 3 quarters · filed 2023-03-30 | $8.45M 10-K · filed 2023-03-30 |
| 2020-09-30 | $2.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $4.55M derived: sum of 2 quarters · filed 2021-11-04 | $5.87M 10-Q · filed 2021-11-04 | $6.27M derived: sum of 4 quarters · filed 2022-03-29 |
| 2020-06-30 | $1.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $3.28M 10-Q · filed 2021-08-09 | $3.68M derived: sum of 3 quarters · filed 2022-03-29 | $4.01M derived: sum of 4 quarters · filed 2022-03-29 |
| 2020-03-31 | $1.32M 10-Q · filed 2021-05-06 | $1.72M derived: sum of 2 quarters · filed 2022-03-29 | $2.06M derived: sum of 3 quarters · filed 2022-03-29 | $2.20M derived: sum of 4 quarters · filed 2022-03-29 |
| 2019-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $734.00K derived: sum of 2 quarters · filed 2022-03-29 | $875.00K derived: sum of 3 quarters · filed 2022-03-29 | $1.01M 10-K · filed 2022-03-29 |
| 2019-09-30 | $334.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $475.00K derived: sum of 2 quarters · filed 2020-11-05 | $614.00K 10-Q · filed 2020-11-05 | $733.00K derived: sum of 4 quarters · filed 2021-03-30 |
| 2019-06-30 | $141.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $280.00K 10-Q · filed 2020-08-06 | $399.00K derived: sum of 3 quarters · filed 2021-03-30 | |
| 2019-03-31 | $139.00K 10-Q · filed 2020-05-07 | $258.00K derived: sum of 2 quarters · filed 2021-03-30 | ||
| 2018-12-31 | $119.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $183.00K 10-K · filed 2021-03-30 | ||
| 2018-09-30 | $64.00K 10-Q · filed 2019-11-07 | |||
| 2017-12-31 | $93.00K 10-K · filed 2020-03-26 |